78 related articles for article (PubMed ID: 24888775)
41. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
[TBL] [Abstract][Full Text] [Related]
42. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant.
Fujiwara M; Horiguchi M; Mori S; Yokoyama K; Horiguchi H; Fukazawa M; Fujiwara H; Yano Y; Satoh H; Kamma H
Pathol Int; 2005 Jun; 55(6):353-9. PubMed ID: 15943793
[TBL] [Abstract][Full Text] [Related]
43. Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases.
Neri A; Megha T; Bettarini F; Tacchini D; Mastrogiulio MG; Marrelli D; Pinto E; Tosi P
Hum Pathol; 2012 Aug; 43(8):1184-91. PubMed ID: 22397869
[TBL] [Abstract][Full Text] [Related]
44. Expression of unusual immunohistochemical markers in mucinous breast carcinoma.
de Andrade Natal R; Derchain SF; Pavanello M; Paiva GR; Sarian LO; Vassallo J
Acta Histochem; 2017 Apr; 119(3):327-336. PubMed ID: 28336164
[TBL] [Abstract][Full Text] [Related]
45. CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast.
García-Labastida L; Garza-Guajardo R; Barboza-Quintana O; Rodríguez-Sanchez IP; Ancer-Rodríguez J; Flores-Gutierrez JP; Gómez-Macías GS
Biol Res; 2014 Sep; 47(1):43. PubMed ID: 25299496
[TBL] [Abstract][Full Text] [Related]
46. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
[TBL] [Abstract][Full Text] [Related]
47. Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.
Cserni G; Floris G; Koufopoulos N; Kovács A; Nonni A; Regitnig P; Stahls A; Varga Z
Virchows Arch; 2017 Jul; 471(1):3-12. PubMed ID: 28528509
[TBL] [Abstract][Full Text] [Related]
48. Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the Breast.
Sugawara-Komatsu K; Fujii T; Kurozumi S; Ishikawa H; Katayama A; Handa T; Tougou M; Sano T; Matsumoto H; Kurosumi M; Horiguchi J; Shirabe K; Oyama T
Anticancer Res; 2024 Jun; 44(6):2689-2698. PubMed ID: 38821605
[TBL] [Abstract][Full Text] [Related]
49. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.
Nonni A; Zagouri F; Sergentanis TN; Lazaris AC; Patsouris ES; Zografos GC
Virchows Arch; 2007 Nov; 451(5):893-7. PubMed ID: 17924141
[TBL] [Abstract][Full Text] [Related]
51. Coexisting lobular neoplasia and carcinoma of the breast.
Haagensen CD; Lane N; Bodian C
Cancer; 1983 Apr; 51(8):1468-82. PubMed ID: 6297702
[TBL] [Abstract][Full Text] [Related]
52. Mucinous carcinoma of the breast co-existent with infiltrating lobular carcinoma--a case report.
Orrell JM; Hussein KA; Irving AD
Cytopathology; 1995 Feb; 6(1):39-43. PubMed ID: 7734700
[No Abstract] [Full Text] [Related]
53. [Reappraisal of invasive lobular carcinoma].
Ding HY; Yang GZ
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):363-5. PubMed ID: 19781339
[No Abstract] [Full Text] [Related]
54. The evolution of lobular neoplasia.
Lerwill MF
Adv Anat Pathol; 2006 Jul; 13(4):157-65. PubMed ID: 16858149
[No Abstract] [Full Text] [Related]
55. [Mucinous lobular carcinoma].
Ab Der Halden C; Taillandier A; Bonneau C; Delalande F; Trehorel L; Michenet P
Ann Pathol; 2023 Jan; 43(1):57-59. PubMed ID: 36270907
[No Abstract] [Full Text] [Related]
56. [Biological features characteristic of the mucinous carcinoma of the breast].
Ruibal A; Arias JI
Rev Esp Med Nucl; 2003; 22(2):122-4. PubMed ID: 12646105
[No Abstract] [Full Text] [Related]
57. Mucinous breast carcinoma with neuroendocrine differentiation: Case report.
Limaiem F; Bouraoui S
Clin Case Rep; 2022 Nov; 10(11):e6665. PubMed ID: 36447661
[TBL] [Abstract][Full Text] [Related]
58. [Course studies in patients with lobular neoplasia of the breast].
Zippel HH; Citoler P; Kievernagel G
Arch Gynakol; 1975 Nov; 219(1-4):150-2. PubMed ID: 1243261
[No Abstract] [Full Text] [Related]
59. Mucinous Carcinoma of the Breast with Neuroendocrine Differentiation.
Varadharajan E; Priya S; Prakash G; Mugundan A; Easwaramurthi P
Iran J Pathol; 2015; 10(3):231-6. PubMed ID: 26351490
[No Abstract] [Full Text] [Related]
60. NEUROENDOCRINE DIFFERENTIATION IN INVASIVE LOBULAR BREAST CARCINOMA.
Gradinaru SE; Bumbea H; Onisai MC; Stoicea M
Acta Endocrinol (Buchar); 2017; 13(2):246-248. PubMed ID: 31149182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
